Loading company details...
Beta
Latest Form 4 (Sep 17, 2026): John A. Orwin (Director): Exercise/Conversion of 1,300 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 17, 2026 | John A. Orwin | Exercise/Conversion | 1,300 | n/a |
| Sep 4, 2026 | J. Anthony Ware | Exercise/Conversion | 39,265 | $225.4K |
| Aug 18, 2026 | Benjamin Stone, Chief Business Officer | Grant/Award | 60,492 | n/a |
| Aug 18, 2026 | Paul F. Lizzul, Chief Medical Officer | Grant/Award | 60,492 | n/a |
| Aug 18, 2026 | Daniel Faga, President, CEO | Grant/Award | 193,575 | n/a |
| Aug 5, 2026 | Benjamin Stone, Chief Business Officer | Grant/Award | 60,492 | n/a |
| Aug 5, 2026 | Paul F. Lizzul, Chief Medical Officer | Grant/Award | 60,492 | n/a |
| Aug 5, 2026 | Daniel Faga, President, CEO | Grant/Award | 193,576 | n/a |
| Jun 17, 2026 | Rita Jain | Exercise/Conversion | 7,330 | n/a |
| Jun 17, 2026 | John P. Schmid | Exercise/Conversion | 6,030 | n/a |